Hope Bancorp (HOPE) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -4.55%. A quarter ago, it was expected that this bank holding company would post earnings of $0.22 per share when it actually produced earnings of $0.22, delivering no surprise. Over the last four quarters, the compa ...

News Release HOPE BANCORP REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS LOS ANGELES – October 28, 2024 – Hope Bancorp, Inc. (the "Company") (NASDAQ: HOPE), the holding company of Bank of Hope (the "Bank"), today reported unaudited financial results for its third quarter and nine months ended September 30, 2024. For the three months ended September 30, 2024, net income totaled $24.2 million, or $0.20 per diluted common share. This compares with net income of $25.3 million, or $0.21 per diluted common share, i ...

Hope Bancorp (HOPE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on October 28, 2024, might help the stock move higher if these key numbers are better tha ...

-Data Supports Deramiocel's Sustained Efficacy and Safety in Treating DMD- -Improvements Seen in Multiple Cardiac and Skeletal Endpoints Demonstrating Stabilization of Cardiac and Skeletal Muscle Function Over 3 Years of Treatment- -Company on Track to Fully Submit Biologics License Application (BLA) by End of 2024- SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...

SAN DIEGO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today that the Company will present the three-year safety and efficacy results from its HOPE-2 open-label extension (OLE) study with lead asset deramiocel for treating Duchenne muscular dystrophy (DMD). The data will highlight the long-term, multi-modal benefits of deramiocel in a late-breaking p ...

Free financial counseling expands in Kentucky one year after the launch of mobile sports betting Partnership with leading organization dedicated to providing access to financial education and empowerment aims to help individuals understand how to best manage their personal finances for long-term financial security NEW YORK, Sept. 17, 2024 /PRNewswire/ -- FanDuel, the premier online gaming company in North America, today announced a second $1 million donation to Operation HOPE, the nation's leading non-profi ...

Funding will Support Youth Impacted by Domestic Violence Across the State RALEIGH, N.C., Sept. 4, 2024 /PRNewswire/ -- WellCare of North Carolina (WellCare), a Medicaid health plan and a Centene Corporation (NYSE: CNC) company, announced today a $100,000 donation available to nine Family Justice Centers across North Carolina. These funds will support Camp HOPE America, a weeklong overnight camp specially designed for youth impacted by domestic violence and trauma. Wellcare of NC (PRNewsfoto/WellCare of Nort ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ______________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-50245 HOPE BANCORP, INC. (Exact name of registrant as specified in its charter) Delaware 95-4849715 (State or other jurisdict ...

Hope Bancorp, Inc. (NASDAQ:HOPE) Q2 2024 Earnings Call Transcript July 29, 2024 12:30 PM ET Company Participants Angie Yang - Director of IR Kevin Kim - Chairman, President, and CEO Julianna Balicka - CFO Conference Call Participants Matthew Clark - Piper Sandler Chris McGratty - KBW Gary Tenner - D.A. Davidson Operator Good day, and welcome to the Hope Bancorp 2024 Second Quarter Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being ...

This presentation contains statements regarding future events or the future financial performance of Hope Bancorp, Inc. ("Company"), including regarding its proposed merger with Territorial Bancorp Inc. ("Territorial") that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, with respect to the proposed merger with ...